Results
627
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
627 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ARES | US$181.06 | 1.5% | 53.0% | US$56.5b | US$185.31 | PE84.5x | E38.4% | 2.1% | Diversified Financials | ||
ALNY | US$243.25 | -1.4% | 27.2% | US$31.4b | US$299.11 | PS15x | E70.3% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$56.45 | -0.3% | 101.6% | US$18.1b | US$59.48 | PE129.2x | E29.4% | n/a | Consumer Durables | ||
RHM | €619.60 | 1.1% | 117.6% | €26.9b | €721.93 | PE39.3x | E29.9% | 0.9% | Capital Goods | ||
CRDO | US$71.22 | 2.0% | 259.2% | US$11.9b | US$73.54 | PS48.5x | E66.3% | n/a | Semiconductors | ||
NVDA | US$140.22 | 7.5% | 184.5% | US$3.4t | US$172.80 | PE54.4x | E25.1% | 0.03% | Semiconductors | ||
SRPT | US$121.90 | -3.1% | 26.6% | US$11.6b | US$185.10 | PE95.6x | E43.0% | n/a | Pharmaceuticals & Biotech | ||
9992 | HK$86.95 | -8.2% | 354.8% | HK$115.3b | HK$91.37 | PE71x | E35.3% | 0.3% | Retail | ||
600760 | CN¥48.17 | -3.7% | 14.3% | CN¥132.7b | CN¥53.90 | PE53.9x | E29.3% | 0.8% | Capital Goods | ||
511243 | ₹1,185.75 | -4.8% | -4.8% | ₹996.9b | ₹1,518.12 | PE25.9x | E21.9% | 0.2% | Diversified Financials | ||
MRVL | US$115.95 | 3.3% | 89.6% | US$100.3b | US$120.80 | PS18.7x | E69.5% | 0.2% | Semiconductors | ||
SUZLON | ₹64.87 | -6.7% | 75.8% | ₹885.3b | ₹74.83 | PE92.3x | E39.4% | n/a | Capital Goods | ||
NU | US$10.37 | -11.4% | 24.9% | US$49.8b | US$15.54 | PB6.5x | E28.6% | n/a | Banks | ||
300308 | CN¥134.99 | 9.4% | 76.4% | CN¥149.1b | CN¥191.56 | PE32.2x | E32.6% | 0.2% | Tech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BESI | €134.95 | 5.0% | -2.1% | €10.8b | €137.18 | PE60.6x | E30.2% | 1.6% | Semiconductors | ||
A196170 | ₩296,000.00 | -1.8% | 222.1% | ₩15.8t | ₩565,000.00 | PS212.1x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
FM | CA$19.00 | 1.0% | 71.9% | CA$15.7b | CA$21.94 | PS2.3x | E72.9% | n/a | Materials | ||
300502 | CN¥122.00 | -5.1% | 159.5% | CN¥86.5b | CN¥151.97 | PE45.4x | E36.7% | 0.1% | Tech | ||
ARGX | €604.60 | 0.9% | 79.5% | €36.5b | €596.31 | PS19.9x | E55.7% | n/a | Pharmaceuticals & Biotech | ||
SOLARINDS | ₹10,178.95 | -3.6% | 49.8% | ₹921.1b | ₹11,698.00 | PE91.1x | E27.0% | 0.08% | Materials | ||
KSPI | US$98.23 | -4.2% | 9.1% | US$18.7b | US$133.84 | PE9.9x | E23.7% | 6.7% | Diversified Financials | ||
BAM | CA$79.77 | -3.7% | 51.2% | CA$33.6b | CA$74.64 | PE51.9x | E88.3% | 2.7% | Diversified Financials | ||
SMCI | US$34.33 | 1.6% | 16.6% | US$20.1b | US$41.93 | PE16.6x | E24.3% | n/a | Tech |